Abstract:Background: Although considerable research has focused on the etiology and symptomology of adductor focal laryngeal dystonia (AD-FLD), little is known about the correlation between clinicians' ratings and patients' perception of this voice disturbance. This study has five objectives: first, to determine if there is a relationship between subjects' symptom-severity and its impact on their quality of life; to compare clinicians' ratings with subjects' perception of the individual characteristics and severity of AD-FLD; to document the subjects' perception of changes in dysphonia since diagnosis; to record the frequency of voice arrest during connected speech; and, finally, to calculate inter-clinician reliability based on results from the Unified Spasmodic Dysphonia Rating Scale (USDRS) (Stewart et al, J Voice 1195-10, 1997). Methods: Sixty subjects with AD-FLD who were receiving ongoing injections of BoNT participated in this study. Subjects' mean age was 60.78 years and their mean duration of symptoms was 16.1 years. Subjects completed the Disease Symptom Questionnaire (DSQ) (specifically designed for this study) and the Voice Handicap Index-10 (VHI-10) (Jacobson et al, Am J Speech Lang Pathol 6:66-70, 1997) to measure the symptoms of their dysphonia and the impact of the disease on their quality of life.Two speech-language pathologists and two laryngologists used the Voice Arrest Measure (VAM) (specifically designed for this study) and the USDRS to independently rate voice recordings of 56/60 subjects. Results: The mean VHI-10 score was 21.3 which is clinically significant. The results of the DSQ and the USDRS were highly correlated. The most severe symptoms identified by both subjects and clinicians were roughness, strain-strangled voice quality, and increased expiratory effort. Voice arrest, aphonia, and tremor were uncommon. Subjects rated their current voice quality at the time of reinjection (i.e., at the time of the study) as significantly better than at the time of their initial AD-FLD diagnosis (p < 0.0001). Inter-clinician reliability on the USDRS was significant at the 0.001 level. Conclusions: The findings from the VHI-10 suggest that AD-FLD has a profound impact on quality of life. The results of the DSQ and the USDRS suggest that there is a strong correlation between subjects' perception and clinicians' assessment of the individual symptoms and the severity of the dysphonia. The findings from the VAM suggest that voice arrests are infrequent in subjects with AD-FLD who are receiving ongoing BoNT injections. The strong inter-clinician reliability on the USDRS suggests that it is an appropriate measure for identifying symptoms and severity of AD-FLD.

Spasmodic dysphonia: introductory phonetic analyses

Effects of Voicing and Syntactic Complexity on Sign Expression in Adductor Spasmodic Dysphonia

Historical approaches to the treatment of Adductor-Type Spasmodic Dysphonia (ADSD): Review and tutorial

Laryngeal Imaging Study of Glottal Attack/Offset Time in Adductor Spasmodic Dysphonia during Connected Speech

Correlating Perceptual Voice Quality in Adductor Spasmodic Dysphonia With Computer Vision Assessment of Glottal Geometry Dynamics

A Novel Acoustic Evaluation Method for the Diagnosis of Adductor Spasmodic Dysphonia

Differentiating Between Adductor and Abductor Spasmodic Dysphonia Using Airflow Interruption

Adductor focal laryngeal Dystonia: correlation between clinicians' ratings and subjects' perception of Dysphonia

[Analysis of vocal fold vibration characteristics of spasmodic dysphonia by laryngeal high speed photography combined with glottis area wave]

The role of laryngoscopy in the diagnosis of spasmodic dysphonia

Supraglottic Laryngeal Maneuvers in Adductor Laryngeal Dystonia During Connected Speech

Deep-Learning-Based Representation of Vocal Fold Dynamics in Adductor Spasmodic Dysphonia during Connected Speech in High-Speed Videoendoscopy

Phonation Threshold Flow and Phonation Threshold Pressure in Patients with Adductor Spasmodic Dysphonia

Tremor Makes a Difference: A Comparative Study of the Demographics and Treatment Outcomes in Patients With Adductor Spasmodic Dysphonia With or Without Vocal Tremor

[Patterns of Spasmodic Dysphonia and Botulinum Toxin Injections].

Transnasal Endoscopic Injection of Botulinum Toxin in Patients with Adductor Spasmodic Dysphonia

Acoustic Effects of Speaker Sex, Speech Sample, and Mandarin Tone on Vowel Production of Poststroke Spastic Dysarthria

Deep Learning-Based Analysis of Glottal Attack and Offset Times in Adductor Laryngeal Dystonia

Comparison of the efficacy and adverse effects of unilateral or bilateral botulinum toxin injections for adductor spasmodic dysphonia: a systematic review and meta-analysis

The Effects of Interactive Context on Acoustic Characteristics of Speech in People With Dysarthria: A Preliminary Study

Botulinum Toxin Therapy for Spasmodic Dysphonia in Japan: The History and an Update